gomphoside: RN given refers to (2alpha(2S,3S,4R,6R),3beta,5alpha)-isomer; structure given in first source
ID Source | ID |
---|---|
PubMed CID | 11237685 |
CHEMBL ID | 2368135 |
MeSH ID | M0151203 |
Synonym |
---|
gomphoside |
CHEMBL2368135 |
3-[(1s,3r,5s,7r,9s,10s,12r,14s,15s,18r,19r,22s,23r)-9,10,22-trihydroxy-7,14,18-trimethyl-4,6,11-trioxahexacyclo[12.11.0.03,12.05,10.015,23.018,22]pentacosan-19-yl]-2h-furan-5-one |
Excerpt | Relevance | Reference |
---|---|---|
" Following an intraperitoneal dosage of [3H]-gomphoside, most of the radioactivity (greater than 80%) had been excreted from the body by the end of 48 hours." | ( The pharmacokinetics and tissue distribution of gomphoside in Wistar rats. Mutlib, AE; Watson, TR, ) | 0.13 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID77374 | Relative ionotropic activity evaluated in guinea pig left atria. | 1985 | Journal of medicinal chemistry, Apr, Volume: 28, Issue:4 | Conformational factors in cardiac glycoside activity. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (16.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |